Higher serum endostatin levels were associated with increased risk of incident CKD, defined as estimated GFR <60 mL/min/1.73 m2 in two independent longitudinal community-based cohorts of Swedish elderly (n = 786; mean age 78 years and n = 815; mean age 75 years, respectively) [94]. This evidence concerns the gene COL18A1 and chronic kidney disease.